TBG Diagnostics Ltd (TDL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:TBG Diagnostics Ltd (TDL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011977
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical research, clinical trials and drug discovery and diagnostic laboratories in hospitals. The company offers its products and services to clients in clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs. It operates research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd (TDL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
TBG Diagnostics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
TBG Diagnostics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
TBG Diagnostics Ltd, Medical Equipment, Deal Details 10
Partnerships 10
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 10
TBG Biotechnology Forms Joint Venture with Xiamen Haicang Biotechnology Development 11
Omixon Enters into Distribution Agreement with TBG Diagnostics 12
Acquisition 13
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 13
Progen Pharma to Acquire TBG 14
Medigen Biotech Acquires Remaining Stake In Texas BioGene 15
TBG Diagnostics Ltd – Key Competitors 16
TBG Diagnostics Ltd – Key Employees 17
TBG Diagnostics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Legal and Regulatory 19
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
TBG Diagnostics Ltd, Medical Equipment, Key Facts, 2016 2
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
TBG Diagnostics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
TBG Diagnostics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
TBG Diagnostics Ltd, Deals By Market, 2011 to YTD 2017 8
TBG Diagnostics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 10
TBG Biotechnology Forms Joint Venture with Xiamen Haicang Biotechnology Development 11
Omixon Enters into Distribution Agreement with TBG Diagnostics 12
TBG Diagnostics to Acquire 51% Stake in RBC Biosciences for USD4 Million 13
Progen Pharma to Acquire TBG 14
Medigen Biotech Acquires Remaining Stake In Texas BioGene 15
TBG Diagnostics Ltd, Key Competitors 16
TBG Diagnostics Ltd, Key Employees 17
TBG Diagnostics Ltd, Other Locations 18
TBG Diagnostics Ltd, Subsidiaries 18

★海外企業調査レポート[TBG Diagnostics Ltd (TDL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fagron NV (FAGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • Specialty Fashion Group Ltd (SFH):企業の財務・戦略的SWOT分析
    Specialty Fashion Group Ltd (SFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Intech Biopharm Ltd (6461):製薬・医療:M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • Trillion Energy International Inc (PKPL):企業の財務・戦略的SWOT分析
    Summary Trillion Energy International Inc (Trillion Energy) formerly Park Place Energy Inc, is an oil and gas company that offers exploration and development of oil and natural gas. The company offers various oil and gas services such as drilling, exploration, development, production, distribution a …
  • Coca-Cola Amatil Limited:戦略・SWOT・企業財務分析
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Umeme Limited (UMEME):企業の財務・戦略的SWOT分析
    Umeme Limited (UMEME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Flowonix Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Flowonix Medical Inc (Flowonix), formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company's products comprise prometra pump, catheter, and accessories and program …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International Plc (Stilo) is a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, smartphone …
  • Sembcorp Industries Ltd (U96):電力:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • Magyar Nemzeti Bank:企業の戦略的SWOT分析
    Magyar Nemzeti Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Indianapolis Power & Light Co-エネルギー分野:企業M&A・提携分析
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • Jordan Emirates Insurance Co PSC:企業の戦略・SWOT・財務情報
    Jordan Emirates Insurance Co PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Emirates Insurance Co PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CIMB Private Banking:企業の戦略・SWOT・財務情報
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cox Enterprises Inc:企業の戦略的SWOT分析
    Cox Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Celsia SA ESP (CELSIA):企業の財務・戦略的SWOT分析
    Summary Celsia SA ESP (Celsia), formerly Compania Colombiana de Inversiones SA ESP, a subsidiary of Grupo Argos SA, is an energy company that generates, transmits, distributes, and sells electricity. The company’s product categories include home line, solar energy, backup energy, thermal network, ef …
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • KSK Energy Ventures Ltd:発電所・企業SWOT分析
    KSK Energy Ventures Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆